Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -5.06 % |
3 Month Return | -11.63 % |
1 Year Return | -19.39 % |
Market Stats | |
Previous Close | ₹693.45 |
Open | ₹703.90 |
Volume | 8,304.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹325.86Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹325.86 Cr |
P/B Ratio | 2.81 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 14.34 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹325.86 Cr | 42.66% | 0.74 | NA | NA | |
NA | ₹64.17 Cr | 258.28% | 0.50 | NA | NA | |
NA | ₹123.98 Cr | 53.7% | 0.69 | NA | NA | |
NA | ₹94.27 Cr | 188.71% | 0.51 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr |
Organisation | Fredun Pharmaceuticals Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 49.24% to 49.48% in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 81.0%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 78.0%
Promoter Holding Down
Promoters have decreased holdings from 49.17% to 48.93% in Sep 2024 quarter
Price Dip
In the last 6 months, Fredun Pharma stock has moved down by -17.7%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 48.93% | ||
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 49.48% | 0.49 | |
Others | 1.59% |
Fredun Pharmaceuticals Ltd’s net profit jumped 8.38% since last year same period to ₹4.27Cr in the Q2 2024-2025. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 3.39% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Fredun Pharmaceuticals Ltd has declared dividend of ₹0.70 - translating a dividend yield of 0.20%.
Read More about DividendsBearish
Neutral
Bullish
Fredun Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Fredun Pharmaceuticals Ltd (539730) share price today is ₹672
Fredun Pharmaceuticals Ltd is not listed on NSE
Fredun Pharmaceuticals Ltd is listed on BSE
Today’s traded volume of Fredun Pharmaceuticals Ltd(539730) is 8,304.00.
Today’s market capitalisation of Fredun Pharmaceuticals Ltd(539730) is ₹325.86Cr.
Fredun Pharmaceuticals Ltd(539730 | Price |
---|---|
52 Week High | ₹1054 |
52 Week Low | ₹650 |
Fredun Pharmaceuticals Ltd(539730) share price is ₹672. It is down -36.24% from its 52 Week High price of ₹1054
Fredun Pharmaceuticals Ltd(539730) share price is ₹672. It is up 3.38% from its 52 Week Low price of ₹650
Fredun Pharmaceuticals Ltd(539730 | Returns |
---|---|
1 Day Returns | -21.45% |
1 Month Returns | -5.06% |
3 Month Returns | -11.63% |
1 Year Returns | -19.39% |